These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31692496)

  • 1. Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy.
    Foo J; Maghnie M; Colao A; Vlachaki I; Colombo G
    Clinicoecon Outcomes Res; 2019; 11():525-537. PubMed ID: 31692496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care.
    Savage MO; Fernandez-Luque L; Graham S; van Dommelen P; Araujo M; de Arriba A; Koledova E
    Patient Prefer Adherence; 2022; 16():1663-1671. PubMed ID: 35846871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.
    Su PH; Yang C; Chao MC; Chiang CL
    JMIR Pediatr Parent; 2021 Jan; 4(1):e14774. PubMed ID: 33448936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Augmented Reality Mobile App (Easypod AR) as a Complementary Tool in the Nurse-Led Integrated Support of Patients Receiving Recombinant Human Growth Hormone: Usability and Validation Study.
    Baños RM; Peltonen LM; Martin B; Koledova E
    JMIR Nurs; 2023 Apr; 6():e44355. PubMed ID: 37083627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of Adherence Monitoring in Adult Patients With Growth Hormone Deficiency Under Replacement Therapy: Preliminary Monocentric Data With Easypod
    Mancini A; Vergani E; Bruno C; Palladino A; Brunetti A
    Front Endocrinol (Lausanne); 2019; 10():416. PubMed ID: 31316468
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility of somatropin (rDNA origin) in the treatment of growth hormone deficiency in children.
    Joshi AV; Munro V; Russell MW
    Curr Med Res Opin; 2006 Feb; 22(2):351-7. PubMed ID: 16466607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of somatropin for the treatment of short children born small for gestational age.
    Christensen T; Buckland A; Bentley A; Djurhuus C; Baker-Searle R
    Clin Ther; 2010 Jun; 32(6):1068-82. PubMed ID: 20637961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(®) for the treatment of adult patients with growth hormone deficiency.
    Beck-Peccoz P; Minuto F; Leal-Cerro A; Zabransky M; Stalla G
    Ther Adv Endocrinol Metab; 2012 Jun; 3(3):85-91. PubMed ID: 23148199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
    Czepielewski MA; Garret Q; Vencio SAC; Rassi N; Felicio JS; Faria MS; Senn CCP; Bronstein MD; Cerqueira MJAG; Neves ACL; Sgarbi JA; Spinola-Castro AM; Cunha MPR; Bandeira F; Toffoletto O; Afiune J; Baradelli R; Rodrigues DG; Scharf M
    Growth Horm IGF Res; 2019; 48-49():29-35. PubMed ID: 31493626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
    Tanner JM; Whitehouse RH; Hughes PC; Carter BS
    J Pediatr; 1976 Dec; 89(6):1000-8. PubMed ID: 993900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
    Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
    Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant growth hormone for children and adolescents with Turner syndrome.
    Baxter L; Bryant J; Cave CB; Milne R
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003887. PubMed ID: 17253498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence and long-term growth outcomes: results from the easypod
    Koledova E; Stoyanov G; Ovbude L; Davies PSW
    Endocr Connect; 2018 Aug; 7(8):914-923. PubMed ID: 29976785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Impact of the TUITEK
    Su PH; Malik S; Jheeta A; Lin YF; Su SH; Koledova E; Graham S
    Front Endocrinol (Lausanne); 2022; 13():897956. PubMed ID: 35600589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.
    Polgreen LE; Thomas W; Orchard PJ; Whitley CB; Miller BS
    Mol Genet Metab; 2014 Feb; 111(2):101-6. PubMed ID: 24368158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human growth hormone for children born small for gestational age: meta-analysis confirms the consistent dose-effect relationship on catch-up growth.
    Crabbé R; von Holtey M; Engrand P; Chatelain P
    J Endocrinol Invest; 2008 Apr; 31(4):346-51. PubMed ID: 18475054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.